DCM
ASMB icon

Dialectic Capital Management’s Assembly Biosciences ASMB Stock Holding History

Dialectic Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,293
Closed -$219K – 88
2016
Q2 		$219K Sell
3,293
-1,446
-31% -$94.9K 0.07% 94
2016
Q1 		$286K Buy
+4,739
New +$317K 0.13% 88

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Dialectic Capital Management's ASMB Position: Q3 2016 in Review

Dialectic Capital Management sold out of Assembly Biosciences (ASMB) in Q3 2016, closing a stake of 3,293 shares — an estimated $219K sold.

Dialectic Capital Management first reported a position in ASMB in Q1 2016 and held it in 2 quarters. The position peaked at $286K in Q1 2016. 36 funds tracked by Wall St. Rank hold ASMB as of Q3 2016.

  • Dialectic Capital Management reported no remaining Assembly Biosciences position as of Q3 2016 after selling out during the quarter.
  • Dialectic Capital Management sold 3,293 Assembly Biosciences shares in Q3 2016, an estimated $219K.
  • Dialectic Capital Management first reported a position in Assembly Biosciences in Q1 2016 and held it in 2 quarters.
  • Dialectic Capital Management's Assembly Biosciences position peaked at $286K in Q1 2016.
  • 36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2016.

Based on Dialectic Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.